| Recent developments in acute coronary syndromes. | |
| | |
MedLine Citation:
|
PMID: 18335668 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Coronary artery disease is the leading cause of death in the UK with a high clinical, social and economic burden. The management of acute coronary syndromes is rapidly evolving and clinicians are constantly challenged with incorporating new clinical pathways and guidelines into their practices. It is important for clinicians to have a sound working knowledge of acute coronary syndromes, and be updated on the emerging evidence to guide therapy and improve outcomes in these patients. |
| | |
Authors:
|
M Bilal Iqbal; Mark A Westwood; R Howard Swanton |
Related Documents
:
|
5572638 - Coronary circulation in acute myocardial infarction. 17520358 - Transcatheter cryoablation with 3-d mapping of an atrial ectopic tachycardia in a pedia... 20144388 - An overview of glycemic control in the coronary care unit with recommendations for clin... 15900998 - Cardiac complications of radiation therapy. 12724648 - Temporal changes and histologic relation of postsystolic thickening in an animal model ... 472308 - Cinefluoroscopy in evaluating left ventricular contractility and aneurysms. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Clinical medicine (London, England) Volume: 8 ISSN: 1470-2118 ISO Abbreviation: Clin Med Publication Date: 2008 Feb |
Date Detail:
|
Created Date: 2008-03-13 Completed Date: 2008-05-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101092853 Medline TA: Clin Med Country: England |
Other Details:
|
Languages: eng Pagination: 42-8 Citation Subset: IM |
Affiliation:
|
The Heart Hospital, University College London Hospitals NHS Trust. biqbal@excite.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary*
/
methods Angiotensin-Converting Enzyme Inhibitors / therapeutic use Anticoagulants / therapeutic use Antithrombins / therapeutic use Heparin, Low-Molecular-Weight / therapeutic use Hirudins Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use Myocardial Infarction / drug therapy, mortality, prevention & control, therapy* Peptide Fragments / therapeutic use Platelet Aggregation Inhibitors / therapeutic use Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors Polysaccharides / therapeutic use Recombinant Proteins / therapeutic use Thrombolytic Therapy* Ticlopidine / analogs & derivatives, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Anticoagulants; 0/Antithrombins; 0/Heparin, Low-Molecular-Weight; 0/Hirudins; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Peptide Fragments; 0/Platelet Aggregation Inhibitors; 0/Platelet Glycoprotein GPIIb-IIIa Complex; 0/Polysaccharides; 0/Recombinant Proteins; 0/fondaparinux; 128270-60-0/bivalirudin; 55142-85-3/Ticlopidine; 90055-48-4/clopidogrel |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Self-poisoning: current trends and practice in a U.K. teaching hospital.
Next Document: Ethical planning for an influenza pandemic.